Lotte van der Weijst

European Organisation for Research and Treatment of Cancer

MedicineEconomics, Econometrics and Finance

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 2 papers. Top paper: “Improving completion rates of patient-reported outcome measures in cancer clinical trials: Scoping review investigating the implications for trial designs”.

Improving completion rates of patient-reported outcome measures in cancer clinical trials: Scoping review investigating the implications for trial designs

European Journal of Cancer(2024)10.1016/j.ejca.2024.114313

N/A

0.449DataRank · unranked

19 citations

Abigirl Machingura, Ahu Alanya, Emma Lidington, Galina Velikova, Hans-Henning Flechtner +18 more

The correlation between pre-treatment symptoms, acute and late toxicity and patient-reported health-related quality of life in non-small cell lung cancer patients: Results of the REQUITE study

Radiotherapy and Oncology(2022)10.1016/j.radonc.2022.09.020

N/A

0.442DataRank · unranked

18 citations

D. Azria, Patrick Berkovic, Pierre Boisselier, Erik Briers, Renée Bultijnck +41 more